VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 6, 2008) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH) (“ALDA”) is pleased to announce that Chinese Patent Number ZL02829642.7 has been issued by the State Intellectual Property Office of the People’s Republic of China. The patent provides protection for the composition and production methods for ALDA’s T36® formulation until August 20, 2022.
